Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Sell
302
-3
-1% -$134 ﹤0.01% 401
2026
Q1
$14.7K Buy
305
+212
+228% +$9.88K 0.01% 292
2025
Q4
$4.51K Buy
93
+76
+447% +$3.77K ﹤0.01% 533
2025
Q3
$803 Buy
17
+3
+21% +$145 ﹤0.01% 945
2025
Q2
$677 Buy
+14
New +$715 ﹤0.01% 915

Other funds holding SNY

Kilter Group's SNY Position: Q2 2026 in Review

Kilter Group reduced its Sanofi (SNY) stake by 0.98% in Q2 2026, selling an estimated $134 and leaving 302 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Kilter Group first reported a position in SNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.7K in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Kilter Group held 302 shares of Sanofi worth $12.9K as of Q2 2026.
  • Kilter Group sold 3 Sanofi shares in Q2 2026, an estimated $134.
  • Sanofi made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #401 holding.
  • Kilter Group first reported a position in Sanofi in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Sanofi position peaked at $14.7K in Q1 2026.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.